Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality

被引:28
作者
McCarron, Paul A. [1 ]
Marouf, Waleed M. [2 ]
Donnelly, Ryan F. [1 ]
Scott, Chris [1 ]
机构
[1] Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland
[2] Hikma Pharmaceut Ltd, Amman 11118, Jordan
关键词
poly(lactide-co-glycolide); nanoparticle; conjugation; polyclonal antibody; bovine serum albumin;
D O I
10.1002/jbm.a.31835
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The density of reactive carboxyl groups on the surface of poly(lactide-co-glycolide) (PLGA) nanoparticles (NP) was modulated using a combination of high-molecular weight (MW) encapped and low MW non-encapped PLGA. Carboxyl groups were activated using carbodiimide chemistry and conjugated to bovine serum albumin and a model polyclonal antibody. Activation of carboxyl,groups in solution-phase PLGA prior to NP formation was compared with a postformation activation of peripheral carboxyl groups on intact NP. Activation before or after NP formation did not influence conjugation efficiency to NP prepared using 100% of the low-MW PLGA. The effect of steric stabilization using poly(vinyl alcohol) reduced conjugation of a polyclonal antibody from 62 mu g/(mg NP) to 32 mu g/(mg NP), but enhanced particulate stability. Increasing the amount of a high-MW PLGA also reduced Conjugation, with the activation post-formation still superior to the preformation approach. Drug release studies showed that high proportions of high-MW PLGA in the NP produced a longer sustained release profile of a model drug (celecoxib). It can be concluded that activating intact PLGA NP is superior to activating component parts prior to NP formation. Also, high MW PLGA could be used to prolong drug release, but at the expense of conjugation efficiency on to the NP surface. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 873-884, 2008
引用
收藏
页码:873 / 884
页数:12
相关论文
共 46 条
[1]   IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE [J].
ALLEMANN, E ;
LEROUX, JC ;
GURNY, R ;
DOELKER, E .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1732-1737
[2]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[3]   Microparticles of novel branched copolymers of lactic acid and amino acids: Preparation and characterization [J].
Caponetti, G ;
Hrkach, JS ;
Kriwet, B ;
Poh, M ;
Lotan, N ;
Colombo, P ;
Langer, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) :136-141
[4]   Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene [J].
Cho, CS ;
Cho, KY ;
Park, IK ;
Kim, SH ;
Sasagawa, T ;
Uchiyama, M ;
Akaike, T .
JOURNAL OF CONTROLLED RELEASE, 2001, 77 (1-2) :7-15
[5]   STUDIES ON THE INVIVO DISPOSITION OF ADRIAMYCIN IN HUMAN-TUMORS WHICH EXHIBIT DIFFERENT RESPONSES TO THE DRUG [J].
CUMMINGS, J ;
MCARDLE, CS .
BRITISH JOURNAL OF CANCER, 1986, 53 (06) :835-838
[6]   A validated spectrofluorometric method for the determination of celecoxib in capsules [J].
Damiani, P ;
Bearzotti, M ;
Cabezón, MA .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2003, 376 (07) :1141-1146
[7]   Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes [J].
Dinauer, N ;
Balthasar, S ;
Weber, C ;
Kreuter, J ;
Langer, K ;
von Briesen, H .
BIOMATERIALS, 2005, 26 (29) :5898-5906
[8]   Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions [J].
Emerich, DF ;
Snodgrass, P ;
Lafreniere, D ;
Dean, RL ;
Salzberg, H ;
Marsh, J ;
Perdomo, B ;
Arastu, M ;
Winn, SR ;
Bartus, RT .
PHARMACEUTICAL RESEARCH, 2002, 19 (07) :1052-1060
[9]   Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting [J].
Fahmy, TM ;
Samstein, RM ;
Harness, CC ;
Saltzman, WM .
BIOMATERIALS, 2005, 26 (28) :5727-5736
[10]   Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate [J].
Faraasen, S ;
Vörös, J ;
Csúcs, G ;
Textor, M ;
Merkle, HP ;
Walter, E .
PHARMACEUTICAL RESEARCH, 2003, 20 (02) :237-246